We're still actively developing this site. If you encounter any issues, please report them! - Report an issue

THE DRUG DEVELOPMENT PROCESS FROM DISCOVERY TO INVESTIGATIONAL NEW DRUG APPLICATION (IND)

PHMSCI 762
Course Description

Overview of the drug development process from discovery to investigational new drug application (IND). Drug discovery (target identification, target validation, and hit-to-lead) preclinical CMC activities, and preclinical pharmacology, pharmacokinetic, and toxicology studies as they apply to both small and large molecule drugs.

Prerequisties

Declared in Pharmaceutical Sciences: Applied Drug Development MS or Capstone Certificate in Applied Drug Development

Satisfies

This course does not satisfy any prerequisites.

Credits

3

Offered

Not Applicable

Grade Point Average
3.44

-2.32% from Historical

Completion Rate
100%

No change from Historical

A Rate
22.58%

-34.52% from Historical

Class Size
31

6.9% from Historical

Instructors (2025 Fall)

Sorted by ratings from Rate My Professors

Similar Courses

INTRODUCTION TO DRUG DEVELOPMENT

PHMSCI 757

Scientific process of drug development from discovery through clinical trials. Brief history of drug development, along with an overview of drug discovery, preclinical, and clinical activities that take place during development. Application to real-world drug development scenarios and challenges, especially as they apply to development of drugs to treat neurological diseases.

CURRENT TRENDS IN DRUG DISCOVERY AND DEVELOPMENT

PHMSCI 759

Provides the experience and skill to find, read and critically analyze scientific and regulatory literature in the field of drug discovery and development.

EARLY DRUG DISCOVERY

BIOMDSCI 820

Examine the early drug discovery process, including target identification and validation, generation of diverse chemical libraries, assay development and high throughput screening, lead optimization by compound profiling, and drug targeting and delivery.

INTRODUCTION TO DATA ANALYSES IN DRUG DEVELOPMENT

PHMSCI 756

Provides a high-level overview of how data analysis techniques augment the drug discovery and development process. Focuses on project-based skills-building through the application of industry-standard software and use of public databases. Explores best practices for data processing and management to ensure experimental reproducibility. Develops troubleshooting skills through critical evaluation of data analysis results and root cause analysis.

THE DRUG DEVELOPMENT PROCESS FROM FIH TO BLA/NDA

PHMSCI 763

Overview of the drug development process from first-in-human (FIH) to submission of a new drug application (NDA) or biologics license application (BLA). Phases of clinical development and the role of biomarkers, companion diagnostics, statistical analysis, and CMC in clinical trials. Both small molecule and protein therapeutics will be addressed.